Human papillomavirus infection and associated cervical disease in human immunodeficiency virus-infected women: Effect of highly active antiretroviraltherapy

Citation
Fb. Lillo et al., Human papillomavirus infection and associated cervical disease in human immunodeficiency virus-infected women: Effect of highly active antiretroviraltherapy, J INFEC DIS, 184(5), 2001, pp. 547-551
Citations number
28
Categorie Soggetti
Clinical Immunolgy & Infectious Disease",Immunology
Journal title
JOURNAL OF INFECTIOUS DISEASES
ISSN journal
00221899 → ACNP
Volume
184
Issue
5
Year of publication
2001
Pages
547 - 551
Database
ISI
SICI code
0022-1899(20010901)184:5<547:HPIAAC>2.0.ZU;2-X
Abstract
To determine the effect of highly active antiretroviral therapy (HAART) on high-risk human papillomavirus (HR-HPV) infections and related cervical les ions, the virologic and cytologic markers of HPV infection were prospective ly studied in 163 human immunodeficiency virus (HIV)- infected women, inclu ding 27 untreated, 62 treated with reverse transcriptase inhibitors, and 74 treated with HAART. A high prevalence of both infections with HR-HPV types (68%) and squamous intraepithelial lesions (SILs; low grade, 20.2%; high g rade, 6.2%) was observed. The risks of infection and disease were inversely correlated with CD4 cell counts (P = .015 and P = .022, respectively). Dur ing the observation period (mean, 15.4 months; range, 6-24 months), CD4 cel l counts increased significantly only in subjects receiving HAART (P < .001 ). Persistence of HR-HPV infection and progression of SILs were comparable in the 3 groups. These results indicate that, even in the era of HAART, HIV -infected women should be monitored carefully for the emergence of high-gra de SILs and cervical cancer.